Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration

被引:118
|
作者
Weigert, Guenther [2 ]
Kaya, Semira [1 ]
Pemp, Berthold [1 ,2 ]
Sacu, Stefan [2 ]
Lasta, Michael [1 ]
Werkmeister, Rene Marcel [3 ]
Dragostinoff, Nikolaus [3 ]
Simader, Christian [2 ]
Garhofer, Gerhard [1 ]
Schmidt-Erfurth, Ursula [2 ]
Schmetterer, Leopold [1 ,3 ]
机构
[1] Med Univ Vienna, Dept Clin Pharmacol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Ophthalmol, A-1090 Vienna, Austria
[3] Med Univ Vienna, Ctr Med Phys & Biomed Engn, A-1090 Vienna, Austria
关键词
EYE DISEASE; VITAMIN-C; MACULOPATHY; CAROTENOIDS; ZEAXANTHIN; EPIDEMIOLOGY; POPULATION; ANCILLARY; PROGRESS; TRIAL;
D O I
10.1167/iovs.11-7522
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. There is evidence from several large-scale clinical trials that reduced intake of lutein, a major component of the macular pigment, is a risk factor for the development of AMD. In the present study (LISA; Lutein Intervention Study Austria) it was hypothesized that lutein supplementation increases macular pigment optical density (MPOD). In addition, an investigation was conducted into whether lutein supplementation improves visual acuity (VA) and macular function (mean differential light threshold; MDLT), as assessed with microperimetry. METHODS. One hundred twenty-six patients with AMD (AREDS [Age-related Eye Disease Study] stages 2, 3, and 4) were included in this randomized (2: 1), placebo-controlled, double-masked parallel group study. Lutein or placebo was administered for 6 months. MPOD was measured with a custom-built reflectometer. VA was assessed with ETDRS (Early Treatment Diabetic Retinopathy Study) charts, and MDLT was assessed with a microperimeter. RESULTS. Lutein significantly increased MPOD by 27.9% +/- 2.9% (P = 0.001 versus placebo). No significant effect of lutein supplementation on MDLT or VA was seen, although a tendency toward an increase was seen for both parameters (MDLT, P = 0.096 versus placebo; VA, P = 0.070 versus placebo). A significant correlation was found, however, between the increase in MPOD after 6 months and the increase in MDLT after 6 months (r = 0.25, P = 0.027), as well as between the increase in MPOD after 6 months and the increase in VA after 6 months (r = 0.27, P = 0.013). CONCLUSIONS. The present study demonstrates that lutein supplementation increases MPOD, as assessed with an objective method. The correlation between the change in MPOD and the change in VA and MDLT indicates that patients who show a pronounced increase in MPOD also benefit in terms of visual function. (ClinicalTrials.gov number, NCT00879671.) (Invest Ophthalmol Vis Sci. 2011; 52: 8174-8178) DOI:10.1167/iovs.11-7522
引用
收藏
页码:8174 / 8178
页数:5
相关论文
共 50 条
  • [41] Macular pigment density in the normal elderly, and subjects with cataracts and age-related macular degeneration
    Ciulla, TA
    Hammond, BR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U43 - U43
  • [42] A Color Perimetric Test to Evaluate Macular Pigment Density in Age-Related Macular Degeneration
    Demirel, Sibel
    Ozmert, Emin
    Batioglu, Figen
    Gedik-Oguz, Yesim
    OPTOMETRY AND VISION SCIENCE, 2016, 93 (06) : 632 - 639
  • [43] Intravitreal Bevacizumab for Age-Related Macular Degeneration with Good Visual Acuity
    Takahashi, Maki
    Sato, Taku
    Kishi, Shoji
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2010, 54 (06) : 565 - 570
  • [44] Intravitreal bevacizumab for age-related macular degeneration with good visual acuity
    Maki Takahashi
    Taku Sato
    Shoji Kishi
    Japanese Journal of Ophthalmology, 2010, 54 : 565 - 570
  • [45] Visual acuity and structural findings in old age-related macular degeneration
    Riusala, A
    Sarna, S
    Immonen, I
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 243 (09) : 947 - 950
  • [46] Visual acuity and structural findings in old age-related macular degeneration
    Aila Riusala
    Seppo Sarna
    Ilkka Immonen
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2005, 243 : 947 - 950
  • [47] Intersession repeatability of visual acuity scores in age-related macular degeneration
    Patel, Praveen J.
    Chen, Fred K.
    Rubin, Gary S.
    Tufail, Adnan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (10) : 4347 - 4352
  • [48] Visit Adherence and Visual Acuity in Exudative Age-Related Macular Degeneration
    Ramakrishnan, Meera S.
    VanderBeek, Brian L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [49] Association Between Macular Pigment Optical Density values and Optical Coherence Tomography Parameters in Age-related Macular Degeneration
    Nigalye, Archana
    Katz, Raviv
    Elze, Tobias
    Pundlik, Shrinivas
    Douglas, Vivian Paraskevi
    Lu, Edward S.
    Tsougranis, Gregory
    Lains, Ines
    Kasetty, Megan
    Husain, Deeba
    Miller, John B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [50] ASSESSMENT OF VISUAL FUNCTION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION AND LOW VISUAL-ACUITY
    ALEXANDER, MF
    MAGUIRE, MG
    LIETMAN, TM
    SNYDER, JR
    ELMAN, MJ
    FINE, SL
    ARCHIVES OF OPHTHALMOLOGY, 1988, 106 (11) : 1543 - 1547